Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study
Ettinger, D S, Finkelstein, D M, Abeloff, M D, Skeel, R T, Stott, P B, Frontiera, M S, Bonomi, P D
Published in JNCI : Journal of the National Cancer Institute (15.07.1992)
Published in JNCI : Journal of the National Cancer Institute (15.07.1992)
Get more information
Journal Article
A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group
Dutcher, J P, Leong, T, Makary, A Z, Bennett, J, Frontiera, M, Miller, H, Wiernik, P H
Published in Leukemia (01.10.1995)
Get more information
Published in Leukemia (01.10.1995)
Journal Article
Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study
Grem, J, O'Dwyer, P, Elson, P, Simon, N, Trump, D, Frontiera, M, Falkson, G, Vogl, S
Published in Journal of clinical oncology (01.10.1991)
Published in Journal of clinical oncology (01.10.1991)
Get more information
Journal Article
Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lung
Schiller, J H, Storer, B, Dreicer, R, Rosenquist, D, Frontiera, M, Carbone, P P
Published in JNCI : Journal of the National Cancer Institute (15.11.1989)
Published in JNCI : Journal of the National Cancer Institute (15.11.1989)
Get more information
Journal Article
Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089
HALLER, Daniel G, CATALANO, Paul J, MACDONALD, John S, O'ROURKE, Mark A, FRONTIERA, Michael S, JACKSON, Don V, MAYER, Robert J
Published in Journal of clinical oncology (01.12.2005)
Published in Journal of clinical oncology (01.12.2005)
Get full text
Journal Article
Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma
Frontiera, M, Murray, J L, Lamki, L, Thomas, J, Satterlee, W, Schmelter, R, Rosenblum, M G, Khazaeli, M B, Unger, M W, Robinson, W A
Published in Clinical nuclear medicine (01.05.1989)
Published in Clinical nuclear medicine (01.05.1989)
Get more information
Journal Article